These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 9224777

  • 1. Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
    Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Hauer MJ, Zhang W, Branstetter DG.
    Drug Metab Dispos; 1997 Jul; 25(7):828-39. PubMed ID: 9224777
    [Abstract] [Full Text] [Related]

  • 2. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
    Chang M, Sood VK, Kloosterman DA, Hauer MJ, Fagerness PE, Sanders PE, Vrbanac JJ.
    Drug Metab Dispos; 1997 Jul; 25(7):814-27. PubMed ID: 9224776
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats.
    Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Hauer MJ, Fagerness PE.
    Drug Metab Dispos; 1997 Feb; 25(2):228-42. PubMed ID: 9029054
    [Abstract] [Full Text] [Related]

  • 4. Absorption, distribution, metabolism, and excretion of atevirdine in the rat.
    Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Schuette MR, Judy RW, Voorman RL, Maio SM, Slatter JG.
    Drug Metab Dispos; 1998 Oct; 26(10):1008-18. PubMed ID: 9763407
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate.
    Borin MT, Chambers JH, Carel BJ, Gagnon S, Freimuth WW.
    Clin Pharmacol Ther; 1997 May; 61(5):544-53. PubMed ID: 9164416
    [Abstract] [Full Text] [Related]

  • 6. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test.
    Cheng CL, Smith DE, Carver PL, Cox SR, Watkins PB, Blake DS, Kauffman CA, Meyer KM, Amidon GL, Stetson PL.
    Clin Pharmacol Ther; 1997 May; 61(5):531-43. PubMed ID: 9164415
    [Abstract] [Full Text] [Related]

  • 7. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK, Woolf EJ, Hoagland VL, Sturgill MG, Deutsch PJ, Yeh KC, Lin JH.
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients.
    Borin MT, Chambers JH, Carel BJ, Freimuth WW, Aksentijevich S, Piergies AA.
    Antiviral Res; 1997 Jun; 35(1):53-63. PubMed ID: 9224961
    [Abstract] [Full Text] [Related]

  • 11. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C, Soliman V.
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [Abstract] [Full Text] [Related]

  • 12. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
    Balani SK, Goldman ME, Kauffman LR, Varga SL, O'Brien JA, Smith SJ, Olah TV, Ramjit HG, Schorn TW, Pitzenberger SM.
    Drug Metab Dispos; 1993 Nov; 21(4):598-604. PubMed ID: 7690697
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Disposition of [1'-(14)C]stavudine after oral administration to humans.
    Zhou L, Kaul S, Liu-Kreyche P, Tran SB, Espina RR, Warrack BM, Roongta VA, Iyer RA.
    Drug Metab Dispos; 2010 Apr; 38(4):655-66. PubMed ID: 20053818
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C, Schwarz T, Kubitza D, Mueck W, Lang D.
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.